Many medical marijuana patients opt to medicate with strains containing higher concentrations of cannabidiol (CBD) because it offers a wide range of therapeutic benefits without producing psychoactive side effects. In recent years, CBD has gained attention for having such a wide range of therapeutic benefits, and so has been a main subject of medical marijuana research. Clinical trials have found CBD could be beneficial for those who suffer from epilepsy, anxiety, schizophrenia, dystonia, graft vs. host disease, nicotine addiction, and THC impairment and withdrawals. All of these will be discussed in more detail in the following post.
CBD is considered to be a safe treatment option due to the fact there has not been any documentation of cannabis-related fatalities. There is no documentation to suggest it produces significant side effects in the central nervous system, mood, or vital signs even at doses of up to 1500 mg/day. At times, however, CBD can cause gastrointestinal upset, diarrhea, sleepiness, dizziness, and changes in appetite. CBD can also affect levels of other drugs in the body because it is metabolized by the same liver enzymes that metabolize other drugs.
This information has been provided by Leaf Science and approved by our Chief Medical Officer. Stay tuned for the next post, in which we will go into greater detail about CBD and its effects on specific illnesses.